Popert said the therapy aimed to treat the cancer effectively and preserve “as much normal prostate tissue and function as possible”.
He added that it could become a new treatment option for some patients, following long-term testing.
The surgeon said he first saw the technology in Australia more than four years ago, and said it was introduced to Guy’s Hospital following regulatory approvals and support from Guy’s Cancer Charity.
He said: “There’s been a study that’s been done in Australia on over 100 patients, and we are replicating that study here in the first 30 patients.
“Although these are still early results, we have been greatly encouraged by what we have seen.
“The ultimate aim is that this treatment will be available within the UK once we get UK Conformity Assessed mark.”
Pilot patients will receive regular follow-ups, including an MRI at one year to assess the long-term durability of the therapy, the hospital said.
The ProFocal Laser Therapy System was purchased through a £125,000 donation from the London Freemasons, administered by Guy’s Cancer Charity.
Listen to the best of BBC Radio London on Sounds and follow BBC London on Facebook, external, X, external and Instagram, external. Send your story ideas to hello.bbclondon@bbc.co.uk, external
